{
  "title": "Indian Drugs, Sold Worldwide, Sometimes Deadly",
  "link": "https://www.nytimes.com/2022/11/03/world/asia/india-gambia-cough-syrup.html",
  "guid": "https://www.nytimes.com/2022/11/03/world/asia/india-gambia-cough-syrup.html",
  "atom:link": "",
  "description": "Deaths believed to be linked to contaminated cough syrups in Gambia have brought attention to loose regulations in India and a lack of testing capacity in poor importing nations.",
  "dc:creator": "Hari Kumar, Saikou Jammeh, Mujib Mashal and Elian Peltier",
  "pubDate": "Thu, 03 Nov 2022 15:02:04 +0000",
  "category": [
    "India",
    "Drugs (Pharmaceuticals)",
    "Hazardous and Toxic Substances",
    "Factories and Manufacturing",
    "Coughs",
    "Syrups",
    "Diethylene Glycol",
    "Ethylene Glycol",
    "International Trade and World Market",
    "Regulation and Deregulation of Industry",
    "Third World and Developing Countries",
    "Gambia",
    "International Relations",
    "Deaths (Fatalities)"
  ],
  "media:content": "",
  "media:credit": "Xavier Galiana/Agence France-Presse â€” Getty Images",
  "media:description": "The deaths of Gambian children were linked to cough syrups produced by Maiden Pharmaceuticals in India."
}